CIK: 0001993440 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $875,204 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 872,049 | $35,231 | 4.0% | $23.11 | 0.0% | COM | 880881107 |
| COGT | COGENT BIOSCIENCES INC | 824,283 | $29,279 | 3.3% | $28.11 | 0.0% | COM | 19240Q201 |
| GH | GUARDANT HEALTH INC | 271,685 | $27,750 | 3.2% | $89.46 | 0.0% | COM | 40131M109 |
| IDYA | IDEAYA BIOSCIENCES INC | 723,653 | $25,017 | 2.9% | $31.88 | 0.0% | COM | 45166A102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 690,528 | $21,489 | 2.5% | $27.43 | 0.0% | COM | 92790C104 |
| FULC | FULCRUM THERAPEUTICS INC | 1,892,683 | $21,406 | 2.4% | $10.18 | 0.0% | COM | 359616109 |
| SRRK | SCHOLAR ROCK HLDG CORP | 459,727 | $20,251 | 2.3% | $37.51 | 0.0% | COM | 80706P103 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 146,303 | $15,660 | 1.8% | $106.08 | 0.0% | COM | 76243J105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 617,714 | $15,443 | 1.8% | $17.79 | 0.0% | COM | 68062P106 |
| RCUS | ARCUS BIOSCIENCES INC | 565,142 | $13,467 | 1.5% | $20.40 | 0.0% | COM | 03969F109 |
| PRAX | PRAXIS PRECISION MEDICINES I | 35,749 | $10,537 | 1.2% | $186.22 | 0.0% | COM NEW | 74006W207 |
| QURE | UNIQURE NV | 321,655 | $7,697 | 0.9% | $38.59 | 0.0% | SHS | N90064101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 381,233 (+30.6%) | $51,411 (+107.5%) | 5.9% | $96.62 | — | SPONSORED ADS | 00370M103 |
| VERA | VERA THERAPEUTICS INC | 601,774 (+69.7%) | $30,474 (+195.8%) | 3.5% | $35.71 | -0.5% | CL A | 92337R101 |
| APGE | APOGEE THERAPEUTICS INC | 474,839 (+17.9%) | $35,841 (+124.0%) | 4.1% | $48.12 | +30.9% | COM | 03770N101 |
| AXSM | AXSOME THERAPEUTICS INC | 206,921 (+35.6%) | $37,792 (+103.9%) | 4.3% | $94.05 | +48.4% | COM | 05464T104 |
| ROIV | ROIVANT SCIENCES LTD | 1,186,817 (+23.7%) | $25,754 (+77.4%) | 2.9% | $13.79 | +43.1% | SHS | G76279101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 893,473 (+24.6%) | $31,343 (+53.7%) | 3.6% | $23.08 | +57.7% | ORDINARY SHARES | N62509109 |
| CYTK | CYTOKINETICS INC | 325,668 (+27.8%) | $20,693 (+47.8%) | 2.4% | $45.77 | +35.9% | COM NEW | 23282W605 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 372,022 | $35,026 | 4.0% | $61.42 | — | — | N5749R100 |
| ACLX | ARCELLX INC | 313,733 | $25,757 | 2.9% | $65.31 | +22.1% | — | 03940C100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 181,897 | $25,535 | 2.9% | $135.50 | +6.9% | — | 64125C109 |
| — | AKERO THERAPEUTICS INC | 397,010 | $18,850 | 2.2% | $49.18 | — | — | 00973Y108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 783,411 | $16,036 | 1.8% | $21.05 | -5.4% | — | 29337E102 |
| JANX | JANUX THERAPEUTICS INC | 639,699 | $15,634 | 1.8% | $42.49 | -44.7% | — | 47103J105 |
| ADMA | ADMA BIOLOGICS INC | 808,673 | $11,855 | 1.4% | $17.93 | -6.0% | — | 000899104 |
| HROW | HARROW INC | 160,234 | $7,720 | 0.9% | $32.60 | +28.8% | — | 415858109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 153,206 (-61.5%) | $12,166 (-53.7%) | 1.4% | $50.06 | +68.8% | COM | 254604101 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,010,307 (-6.9%) | $16,444 (-36.5%) | 1.9% | $10.42 | +10.5% | COM | 68622P109 |
| ARGX | ARGENX SE | 23,256 (-40.0%) | $19,557 (-31.6%) | 2.2% | $388.36 | — | SPONSORED ADR | 04016X101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 63,580 (-25.5%) | $30,979 (-13.4%) | 3.5% | $336.31 | +38.5% | COM | 91307C102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 481,564 (-15.6%) | $38,039 (-9.1%) | 4.3% | $33.08 | +117.0% | COM | 604749101 |
| NUVL | NUVALENT INC | 368,697 (-6.6%) | $37,087 (+8.6%) | 4.2% | $71.10 | +38.7% | COM | 670703107 |
| ASND | ASCENDIS PHARMA A/S | 131,808 (-9.9%) | $28,107 (-3.4%) | 3.2% | $144.94 | — | SPONSORED ADR | 04351P101 |
| KYMR | KYMERA THERAPEUTICS INC | 206,445 (-25.7%) | $16,063 (+2.2%) | 1.8% | $45.10 | +49.7% | COM | 501575104 |
| INSM | INSMED INC | 264,293 (-17.3%) | $45,998 (-0.1%) | 5.3% | $48.11 | +279.3% | COM PAR $.01 | 457669307 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 638,385 | $50,847 | 5.8% | $45.05 | +45.5% | COM | 76155X100 |
| BBIO | BRIDGEBIO PHARMA INC | 595,473 | $45,548 | 5.2% | $29.85 | +119.9% | COM | 10806X102 |
| NTRA | NATERA INC | 80,875 | $18,528 | 2.1% | $128.20 | +62.7% | COM | 632307104 |
| XENE | XENON PHARMACEUTICALS INC | 799,743 | $35,844 | 4.1% | $37.92 | +10.8% | COM | 98420N105 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 262,643 | $3,462 | 0.4% | $52.12 | -77.4% | CLASS A ORD | 61559X104 |